OVID THERAPEUTICS INC shareholders Q3 2023

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

OVID THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 4,037$15,5020.00%
Allspring Global Investments Holdings, LLC 6,294$24,1680.00%
BARCLAYS PLC 10,780$410.00%
ROYAL BANK OF CANADA 12,819$49,0000.00%
D. E. Shaw & Co., Inc. 84,308$323,7430.00%
VANGUARD GROUP INC 2,966,417$11,391,0420.00%
Mirae Asset Global Investments Co., Ltd. 32,231$123,7670.00%
VOYA INVESTMENT MANAGEMENT LLC 25,825$99,1680.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 13,157$50,5230.00%
UBS Group AG 48,107$184,7310.00%
RHUMBLINE ADVISERS 82,791$317,9090.00%
BNP PARIBAS FINANCIAL MARKETS 8,650$33,2160.00%
OSAIC HOLDINGS, INC. 306$1,1750.00%
FMR LLC 91,506$351,3830.00%
DIMENSIONAL FUND ADVISORS LP 142,858$548,5760.00%
BANK OF AMERICA CORP /DE/ 39,696$152,4330.00%
FIRST MANHATTAN CO. LLC. 26,000$99,8400.00%
Russell Investments Group, Ltd. 57$2190.00%
NORTHERN TRUST CORP 478,810$1,838,6300.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
External links

This page lists OVID THERAPEUTICS INC's shareholders in Q3 2023. To view OVID THERAPEUTICS INC's shareholder history, click here.